Encision Inc
Encision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. It operates through two segments, Product and Service. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. The AEM instruments product lin… Read more
Encision Inc (ECIA) - Net Assets
Latest net assets as of September 2025: $-2.39 Million USD
Based on the latest financial reports, Encision Inc (ECIA) has net assets worth $-2.39 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($-201.62K) and total liabilities ($2.19 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-2.39 Million |
| % of Total Assets | 1187.21% |
| Annual Growth Rate | -6.35% |
| 5-Year Change | -41.07% |
| 10-Year Change | -32.94% |
| Growth Volatility | 21.27 |
Encision Inc - Net Assets Trend (1997–2025)
This chart illustrates how Encision Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Encision Inc (1997–2025)
The table below shows the annual net assets of Encision Inc from 1997 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $1.65 Million | -9.62% |
| 2024-03-31 | $1.83 Million | -26.78% |
| 2023-03-31 | $2.50 Million | -9.14% |
| 2022-03-31 | $2.75 Million | -2.00% |
| 2021-03-31 | $2.80 Million | +28.30% |
| 2020-03-31 | $2.18 Million | -7.13% |
| 2019-03-31 | $2.35 Million | +6.70% |
| 2018-03-31 | $2.20 Million | +22.31% |
| 2017-03-31 | $1.80 Million | -26.81% |
| 2016-03-31 | $2.46 Million | -24.66% |
| 2015-03-31 | $3.27 Million | -28.77% |
| 2014-03-31 | $4.59 Million | +4.41% |
| 2013-03-31 | $4.39 Million | -7.23% |
| 2012-03-31 | $4.74 Million | +26.18% |
| 2011-03-31 | $3.75 Million | +3.05% |
| 2010-03-31 | $3.64 Million | +11.72% |
| 2009-03-31 | $3.26 Million | +11.34% |
| 2008-03-31 | $2.93 Million | +0.18% |
| 2007-03-31 | $2.92 Million | +7.02% |
| 2006-03-31 | $2.73 Million | -8.13% |
| 2005-03-31 | $2.97 Million | -1.86% |
| 2004-03-31 | $3.03 Million | +51.02% |
| 2003-03-31 | $2.01 Million | +13.18% |
| 2002-03-31 | $1.77 Million | -10.28% |
| 2001-03-31 | $1.98 Million | -32.18% |
| 2000-03-31 | $2.91 Million | -40.88% |
| 1999-03-31 | $4.93 Million | -30.66% |
| 1998-03-31 | $7.11 Million | -31.38% |
| 1997-03-31 | $10.36 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Encision Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1583600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $24.42 Million | 1478.79% |
| Total Equity | $1.65 Million | 100.00% |
Encision Inc Competitors by Market Cap
The table below lists competitors of Encision Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Rare Earth Magnesium Technology Group Holdings Limited
STU:GPS
|
$1.54 Million |
|
True North Gems Inc
PINK:TNGMF
|
$1.54 Million |
|
Union Pioneer Public Company Limited
BK:UPF
|
$1.54 Million |
|
Walker Lane Resources Ltd.
V:WLR
|
$1.55 Million |
|
Northern Lights Resources Corp
PINK:NLRCF
|
$1.54 Million |
|
Shaniv
TA:SHAN
|
$1.54 Million |
|
Electroarges S
RO:ELGS
|
$1.54 Million |
|
Haute Capital Partners AG
SW:HAUTE
|
$1.54 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Encision Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 1,826,748 to 1,651,102, a change of -175,646 (-9.6%).
- Net loss of 220,198 reduced equity.
- Other factors increased equity by 44,552.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-220.20K | -13.34% |
| Other Changes | $44.55K | +2.7% |
| Total Change | $- | -9.62% |
Book Value vs Market Value Analysis
This analysis compares Encision Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.45x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.24x to 3.45x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1997-03-31 | $2.03 | $0.48 | x |
| 1998-03-31 | $1.32 | $0.48 | x |
| 1999-03-31 | $0.92 | $0.48 | x |
| 2000-03-31 | $0.54 | $0.48 | x |
| 2001-03-31 | $0.37 | $0.48 | x |
| 2002-03-31 | $0.33 | $0.48 | x |
| 2003-03-31 | $0.34 | $0.48 | x |
| 2004-03-31 | $0.50 | $0.48 | x |
| 2005-03-31 | $0.48 | $0.48 | x |
| 2006-03-31 | $0.40 | $0.48 | x |
| 2007-03-31 | $0.45 | $0.48 | x |
| 2008-03-31 | $0.45 | $0.48 | x |
| 2009-03-31 | $0.51 | $0.48 | x |
| 2010-03-31 | $0.56 | $0.48 | x |
| 2011-03-31 | $0.58 | $0.48 | x |
| 2012-03-31 | $0.73 | $0.48 | x |
| 2013-03-31 | $0.54 | $0.48 | x |
| 2014-03-31 | $0.51 | $0.48 | x |
| 2015-03-31 | $0.31 | $0.48 | x |
| 2016-03-31 | $0.23 | $0.48 | x |
| 2017-03-31 | $0.17 | $0.48 | x |
| 2018-03-31 | $0.21 | $0.48 | x |
| 2019-03-31 | $0.22 | $0.48 | x |
| 2020-03-31 | $0.19 | $0.48 | x |
| 2021-03-31 | $0.24 | $0.48 | x |
| 2022-03-31 | $0.24 | $0.48 | x |
| 2023-03-31 | $0.21 | $0.48 | x |
| 2024-03-31 | $0.16 | $0.48 | x |
| 2025-03-31 | $0.14 | $0.48 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Encision Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -13.34%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3.36%
- • Asset Turnover: 1.79x
- • Equity Multiplier: 2.22x
- Recent ROE (-13.34%) is above the historical average (-16.62%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1997 | -28.03% | -207.67% | 0.12x | 1.09x | $-3.94 Million |
| 1998 | -44.95% | -242.78% | 0.17x | 1.06x | $-3.91 Million |
| 1999 | -44.22% | -138.95% | 0.29x | 1.10x | $-2.67 Million |
| 2000 | -67.49% | -98.21% | 0.59x | 1.16x | $-2.26 Million |
| 2001 | -50.13% | -32.82% | 1.19x | 1.29x | $-1.19 Million |
| 2002 | -12.16% | -4.43% | 2.02x | 1.36x | $-392.85K |
| 2003 | 10.68% | 3.15% | 2.32x | 1.46x | $13.71K |
| 2004 | 0.17% | 0.07% | 1.88x | 1.28x | $-298.00K |
| 2005 | -20.01% | -7.39% | 1.96x | 1.38x | $-892.49K |
| 2006 | -12.37% | -3.70% | 2.39x | 1.40x | $-610.97K |
| 2007 | -3.08% | -0.82% | 2.51x | 1.50x | $-382.43K |
| 2008 | -6.12% | -1.49% | 2.44x | 1.69x | $-472.19K |
| 2009 | 4.90% | 1.25% | 2.57x | 1.52x | $-166.27K |
| 2010 | 7.27% | 2.06% | 2.40x | 1.47x | $-99.30K |
| 2011 | 0.12% | 0.04% | 2.15x | 1.44x | $-370.84K |
| 2012 | -11.20% | -4.09% | 2.03x | 1.35x | $-1.00 Million |
| 2013 | -14.02% | -5.23% | 1.97x | 1.36x | $-1.06 Million |
| 2014 | -38.84% | -16.89% | 1.70x | 1.35x | $-2.24 Million |
| 2015 | -42.32% | -14.30% | 2.05x | 1.45x | $-1.71 Million |
| 2016 | -35.74% | -9.43% | 2.45x | 1.55x | $-1.13 Million |
| 2017 | -40.46% | -8.22% | 2.89x | 1.70x | $-909.20K |
| 2018 | 15.25% | 3.84% | 2.69x | 1.48x | $115.60K |
| 2019 | -10.04% | -2.68% | 2.57x | 1.46x | $-471.26K |
| 2020 | -11.05% | -3.15% | 1.62x | 2.17x | $-459.83K |
| 2021 | 20.87% | 7.76% | 1.33x | 2.02x | $304.53K |
| 2022 | 16.87% | 6.04% | 1.60x | 1.75x | $188.74K |
| 2023 | -14.67% | -4.98% | 1.78x | 1.66x | $-615.50K |
| 2024 | -37.87% | -10.50% | 1.73x | 2.09x | $-874.46K |
| 2025 | -13.34% | -3.36% | 1.79x | 2.22x | $-385.31K |
Industry Comparison
This section compares Encision Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Encision Inc (ECIA) | $-2.39 Million | -28.03% | N/A | $1.54 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |